Palmitoyl Tripeptide-8 CAS 936544-53-5 Manufacturer and Supplier

Min.Order: 1
Product origin: Hangzhou, Zhejiang, China
Infringement complaint: complaintComplaint
US$ 1

Description
Hangzhou Jinlan Pharm-Drugs Technology Co., Ltd. (JL Pharm)  is established in 2012 at the beautiful West Lake - Hangzhou city, China. The company's main business includes R&D, Production and Sales of Formulation, APIs, and intermediates. The company's main products include Antiviral products, Contrast Media, related formulation, intermediates, and new product development.

We has a laboratory of 1200 square meters in Nanjing city, and has cooperative GMP production plants in Beijing, Jiangsu, Zhejiang, Jiangxi, Chengdu and Shandong. We have more than 80 technical staff, the company's management team has experience in R&D, GMP production, analysis, registration, etc. The technical management level is in a leading position in the pharmaceutical industry. We provide CDMO technology research and development services, and provides a full range of laboratory R&D and production services for raw materials and pharmaceutical intermediates to global pharmaceutical companies, including synthetic route research and development, process research and development and optimization, scale-up production, domestic and foreign drug registration, and industrial equipment selection, automatic control system and technical process packages.

Antivial products include: Redisevir, Hydroxychloroquine Sulfate, Abidol Sulfate, Oseltamivir Phosphate, Ritonavir, Lopinavir, etc. And related preparations and intermediates.

Contrast products: Iohexol, Iopamidol, Iodixanol, Iopromide, Ioversol, Iomepride, Gadopentate meglumine, Gadoterate, etc. And related preparations and intermediates.

 

 


Basic Info

Chemical Name

Palmitoyl tripeptide-8

Synonyms

L-Argininamide, N-(1-oxohexadecyl)-L-histidyl-D-phenylalanyl-;

CAS No.

936544-53-5

Molecular Formula

C37H61N9O4

Molecular Weight

695.93800

PSA

220.97000

LogP

6.94310

Product Tag:
Related categories:
Scroll to Top